Another study has reported that activation of IL-6 signalling is correlated with aggressive tumour behaviour and EMT changes in pharyngeal cancer [43], lymph node metastasis and disease recurrence [25], while activated IL-6Ra/gp130 signalling induced various pathways. The gene discussed is IL6; the disease is neoplasm.